Concepedia

M K Bowling

MK

9

Publications

738

Citations

9

H-Index

1995

Active since

Affiliations

Johns Hopkins University(Current)

M K Bowling is an author at Johns Hopkins University specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1995–2001

9

Publications

9

A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.

Jeremy L. Gilbert, Sharyn D. Baker, M K Bowling et al. · PubMed · 2001 · 209 citations

A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.

Michael A. Carducci, Jeremy L. Gilbert, M K Bowling et al. · PubMed · 2001 · 204 citations

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.

Eric K. Rowinsky, Scott H. Kaufmann, Sharyn D. Baker et al. · Journal of Clinical Oncology · 1996 · 145 citations

Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors.

Eric K. Rowinsky, L B Grochow, S E Sartorius et al. · Journal of Clinical Oncology · 1996 · 52 citations

A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia.

Eric K. Rowinsky, Scott H. Kaufmann, Sharyn D. Baker et al. · PubMed · 1996 · 42 citations

, , +14

Rows per page

1–5 of 9